IP Library Granted Patent US 10,478,130
Granted Patent B2
US 10,478,130 · App. 14/973,390 · Granted Nov 19, 2019

Plaque vulnerability assessment in medical imaging

Inventors: Puneet Sharma (Monmouth Junction, NJ); Dorin Comaniciu (Princeton Junction, NJ)
Assignee: Siemens Healthcare GmbH
A61B5/7275A61B5/021A61B5/026A61B5/02007A61B5/055A61B5/14546A61B5/7267A61B6/461A61B6/504A61B6/5217A61B8/0891A61B8/5223A61B5/742A61B6/032
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,478,130
App. No.
14/973,390
Granted
Nov 19, 2019
Kind
B2
Abstract

Rather than rely on variation from physician to physician and limited imaging information for assessing plaque vulnerability of a patient, medical imaging and other information are used by a machine-implemented classifier to predict plaque rupture. Anatomical, morphological, hemodynamic, and biochemical features are used in combination to classify plaque.

Claims (28)

1. A method for assessing plaque vulnerability of a patient in medical imaging, the method comprising:

extracting an anatomical feature of a vessel or plaque and a morphological feature of the plaque from a scan of the patient by a medical imaging scanner;

obtaining a hemodynamic feature of the patient from a hemodynamic sensor or personalized modeling of the vessel based on the scan;

receiving at an interface a biochemical feature from a blood test of the patient, the biochemical feature including a level of high sensitive troponin;

calculating by a machine-implemented classifier a risk score for plaque rupture for the patient and a risk stratification, both the risk score and risk stratification calculated by the machine-implemented classifier from the anatomical, morphological, hemodynamic, and biochemical features; and

transmitting the risk score for the patient to a display.

2. The method of claim 1 wherein extracting the morphological feature comprises extracting a type of the plaque from an angiography as the scan.

3. The method of claim 1 wherein extracting the anatomical feature comprises extracting a shape, geometry, inlet angle, outlet angle, location of the plaque relative to the vessel, stenosis of the vessel, vessel size, vessel shape, or combinations thereof.

4. The method of claim 1 wherein extracting comprises extracting automatically with a processor or semi-automatically with the processor and a user input.

5. The method of claim 1 wherein obtaining comprises obtaining a pressure, flow, or pressure and flow and calculating stress from the pressure, flow, or pressure and flow.

6. The method of claim 1 wherein the level of high sensitive troponin is a level of high sensitive troponin T.

7. The method of claim 1 wherein calculating comprises calculating by the machine-implemented classifier as a weighted sum of ranks mapped from each of the anatomical, morphological, hemodynamic, and biochemical features, the weights based on clinical literature.

8. The method of claim 1 wherein calculating comprises calculating by the machine-implemented classifier comprises a mechanistic model.

9. The method of claim 1 wherein calculating comprises calculating by the machine-implemented classifier comprising a machine-learnt classifier.

10. The method of claim 1 wherein calculating comprises calculating the risk score as part of the risk stratification and a plaque vulnerability assessment for the patient in a coronary artery disease analysis.

11. The method of claim 1 wherein calculating comprises calculating the risk score for the patient in an acute coronary syndrome analysis.

12. The method of claim 1 further comprising repeating extracting, obtaining, and calculating for another plaque.

13. The method of claim 1 further comprising performing the scan with the medical imaging scanner comprising a non-invasive modality, wherein the anatomical, morphological, and hemodynamic features are all obtained without invasion of the patient.

14. A method for assessing plaque vulnerability of a patient in medical imaging, the method comprising:

loading a morphological characteristic of plaque of a patient, a hemodynamic characteristic, an anatomy characteristic of a vessel with the plaque, and a biochemical characteristic of the plaque as an input feature vector, where a biochemical characteristic is a level of high sensitive troponin;

classifying a vulnerability of the plaque of the patient by a machine-trained classifier in response to the input feature vector, the classifying being part of a risk stratification based on the hemodynamic, biochemical, and anatomy characteristics; and

signaling a result of the classifying to a user.

15. A method for assessing plaque vulnerability of a patient in medical imaging, the method comprising:

extracting an anatomical feature of a vessel or plaque and a morphological feature of the plaque from a scan of the patient by a medical imaging scanner;

obtaining a hemodynamic feature of the patient from a hemodynamic sensor or personalized modeling of the vessel based on the scan;

receiving at an interface a biochemical feature from a blood test of the patient, the receiving comprising receiving a level of high sensitive troponin;

calculating by a machine-implemented classifier a risk score for plaque rupture for the patient and a risk stratification, both the risk score and risk stratification calculated by the machine-implemented classifier from the anatomical, morphological, hemodynamic, and biochemical features; and

transmitting the risk score for the patient to a display.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2023
From: SIEMENS HEALTHCARE GMBH
To: SIEMENS HEALTHINEERS AG
Reel/Frame 066267/0346 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 25, 2016
From: SIEMENS AKTIENGESELLSCHAFT
To: SIEMENS HEALTHCARE GMBH
Reel/Frame 040416/0164 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 24, 2016
From: SIEMENS CORPORATION
To: SIEMENS AKTIENGESELLSCHAFT
Reel/Frame 039528/0187 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2016
From: COMANICIU, DORIN; SHARMA, PUNEET
To: SIEMENS CORPORATION
Reel/Frame 038926/0442 →
Continuity (2)
Provisional Application 62115713 · Feb 13, 2015
Related Publication 20160235373A1 · Aug 18, 2016
Cited By (19)
US 12,245,882 US 12,283,046 US 12,299,885 US 12,324,695 US 12,324,696 US 12,380,560 US 12,396,695 US 12,406,365 US 12,440,180 US 12,499,539 US 12,502,150 US 12,505,547 US 12,555,228 US 12,558,048 US 12,599,352 US 12,620,092 US 12,635,965 US 12,712,082 US 12,714,382